Login to Your Account



NewCo News

Start-up Allecra Gets $20M for Antibiotic Development

By Cormac Sheridan
Staff Writer

Wednesday, April 24, 2013
Allecra Therapeutics GmbH, a Franco-German start-up raised €15 million (US$19.6 million) in a Series A round to take two antibiotic development programs into the clinic and through clinical proof of concept.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription